Copyright
©The Author(s) 2015.
World J Cardiol. Aug 26, 2015; 7(8): 454-465
Published online Aug 26, 2015. doi: 10.4330/wjc.v7.i8.454
Published online Aug 26, 2015. doi: 10.4330/wjc.v7.i8.454
Cell type | Animal model | Expression of VEC markers | Expression of VSMC markers | Expression of cardiomyocyte markers | Functional recovery | Ref. |
Human cADSCs | Murine hindlimb ischemia | CD31 | NE | NE | Yes | Planat-Benard et al[31] |
Porcine cADSCs | Porcine AMI | vWF | SMA | NE | Yes | Valina et al[37] |
Human cADSCs | Bladders and urethras of athymic rats and SCID mice | NE | SMA | NE | NE | Jack et al[38] |
Murine fADSCs | Murine AMI | NE | NE | Myosin heavy chain, Nkx2.5, troponin I | Yes | Strem et al[39] |
Murine fADSCs | Rat AMI | NE | NE | Sarcomeric actin, GATA-4 | Yes | Yamada et al[40] |
Conditioned medium from human cADSCs | Murine hindlimb ischemia | NE | NE | NE | Yes | Bhang et al[48] |
- Citation: Suzuki E, Fujita D, Takahashi M, Oba S, Nishimatsu H. Adipose tissue-derived stem cells as a therapeutic tool for cardiovascular disease. World J Cardiol 2015; 7(8): 454-465
- URL: https://www.wjgnet.com/1949-8462/full/v7/i8/454.htm
- DOI: https://dx.doi.org/10.4330/wjc.v7.i8.454